AR folding and hormone-dependent activation is dependent upon the dynamic, ordered assembly of heteromeric complexes involving multiple chaperone and cochaperone proteins (reviewed in [4]), many of which are potential therapeutic targets for prostate cancer treatment (reviewed in [5]). The gene discussed is AR; the disease is prostate carcinoma.